1. Japan Stocks

  2. •

    Technology services

  3. •

    Packaged software
Welby Inc.

Welby Inc.

TTSE:4438
296.00
JPY
-19.00
(-6.03%)
2.03BMarket Cap
Nov 13Next Earn
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
32.83
81.13
142.72
103.81
110.64
145.44
134.18
73.47
64.71
76.82
- -
Basic EPS, GAAP
-17.67
-13.15
31.19
-1.47
-45.18
-16.68
4.33
-64.51
-98.61
-65.21
- -
Free Cash Flow per Basic Share
-18.4
-5.67
-0.99
-30.44
-19.85
-14.74
-18.75
-33.03
-95.13
-52.05
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
17.75
143.77
167.56
214.31
173.32
160.77
162.67
139.24
97.88
32.91
10.55
Tangible Book Value per Share
17.62
143.63
167.38
209.27
173.32
160.77
162.67
139.24
83.07
20.79
-9.71
Basic Weighted Avg Shares
8
6
6
8
8
8
8
8
8
8
8
Sales/Revenue/Turnover
253
475
808
799
865
1,139
1,051
575
528
636
- -
Operating Margin (%)
-53.73
-15.45
19.32
2.07
-27.47
-9.93
5.8
-75.99
-123.94
-71.23
- -
Depreciation Expense
6
4
5
8
22
1
2
3
23
29
- -
Net Income, GAAP
-136
-77
177
-11
-353
-131
34
-505
-805
-540
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
11.12
- -
- -
- -
- -
Profit Margin (%)
-53.82
-16.21
21.85
-1.42
-40.84
-11.47
3.23
-87.8
-152.37
-84.89
- -
Working Capital
104
1,071
1,171
1,541
1,314
1,194
1,232
1,044
644
519
175
LT Debt
- -
37
30
23
15
8
1
- -
- -
388
318
Total Equity
132
1,067
1,243
1,668
1,358
1,259
1,274
1,118
838
306
108
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
4.14
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
2.66
- -
- -
- -
- -
Return on Common Equity (%)
- -
-12.84
15.29
-0.78
-23.34
-9.99
2.68
-42.74
-84.67
-99.73
- -

Capital Structure

JPY

•

in mil. unless spec.
Jun'24
Mar'26
Jun'26
ST Debt
200
- -
217
LT Borrowings
- -
- -
318
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
8
8
8
Market Capitalization
4,448
2,708
2,033

Working Capital

JPY

•

in mil. unless spec.
Jun'24
Mar'26
Jun'26
Total Current Assets
1,409
- -
594
Cash, Cash Equivalents & STI
1,306
- -
436
Accounts Receivable, Net
42
- -
79
Inventories
18
- -
56
Total Current Liabilities
367
- -
419
Payables & Accruals
- -
- -
- -
ST Debt
200
- -
217
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-21.36%
-63.46%
Free Cash Flow
- -
46.67%
-44.51%
Net Income, GAAP
- -
-350.55%
-32.93%
Sales/Revenue/Turnover
- -
-1.82%
20.39%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
103
82
- -
- -
528
2025
- -
- -
- -
- -
636
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-16.46
-22.25
- -
- -
-98.61
2025
- -
- -
- -
- -
-65.21
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Takeru Hiki
Full Time Employees
44
Sector
Technology services
Industry
Packaged software
Address
Kanden Real Estate Yaesu Building Tokyo Japan 104-0031
IPO Date
Mar 29, 2019
Website
welby.jp
Similar Companies
Microsoft Corporation (NASDAQ:MSFT)
Palantir Technologies Inc. (NASDAQ:PLTR)
Nebius Group N.V. (NASDAQ:NBIS)
Oracle Corporation (NYSE:ORCL)
CoreWeave, Inc. (NASDAQ:CRWV)
ServiceNow, Inc. (NYSE:NOW)
Business
Welby Inc. (4438.T) develops and provides personal health record (PHR) platforms and digital health solutions that enable patients to manage medical data and support self-management of chronic conditions. The company operates primarily through two segments: Medical Solution Services, which delivers customized electronic health and medical record platforms developed in collaboration with pharmaceutical companies, medical device manufacturers, governments, and healthcare providers; and Welby MyKarte Services, featuring the free smartphone application "Welby MyKarte" for recording and visualizing metrics such as blood glucose levels, blood pressure, weight, exercise activity, medication adherence, and meals, with automated data integration from compatible devices and sharing capabilities with healthcare professionals via graphs, tables, and reports. These services target patients with lifestyle-related diseases including diabetes, hypertension, and obesity, as well as mental illness, autoimmune diseases, neurological disorders, rare diseases, oncology, and pain management; the company also conducts medical data surveys and operates web-based tools. Founded in 2011 and headquartered at 1-11-1 Kyobashi, 4th Floor, KEPCO Real Estate Yaesu Building, Chuo-ku, Tokyo 104-0031, Japan, Welby focuses on patient-centered healthcare primarily in Japan, partnering with entities like Suzuken Co. Ltd., which increased its stake to a significant holding via a 2023 acquisition from Digital Garage Inc., and Chubu Electric Power Co. for PHR service expansion. In recent developments, Welby entered a 2024 business alliance with Chubu Electric Power and Suzuken to accelerate PHR adoption through joint development of consumer healthcare apps and medical institution services, including a partial stake sale in MeDaCa Inc. to Suzuken; the company released Welby MyKarte app version 3.0.5 in 2025 with enhanced usability and historical data input features; and it hosted the "Rework Forum 2025" for HR and general affairs professionals, alongside ongoing co-development of disease-specific tools like Nikibi Log with Maruho Co. and MyKarte ONC with Chugai Pharmaceutical.